Literature DB >> 10877932

Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation.

T Ostenfeld1, M A Caldwell, K R Prowse, M H Linskens, E Jauniaux, C N Svendsen.   

Abstract

Worldwideattention is presently focused on proliferating populations of neural precursor cells as an in vitro source of tissue for neural transplantation and brain repair. However, successful neuroreconstruction is contingent upon their capacity to integrate within the host CNS and the absence of tumorigenesis. Here we show that human neural precursor cells express very low levels of telomerase at early passages (less than 20 population doublings), but that this decreases to undetectable levels at later passages. In contrast, rodent neural precursors express high levels of telomerase at both early and late passages. The human neural precursors also have telomeres (approximately 12 kbp) significantly shorter than those of their rodent counterparts (approximately 40 kbp). Human neural precursors were then expanded 100-fold prior to intrastriatal transplantation in a rodent model of Parkinson's disease. To establish the effects of implanted cell number on survival and integration, precursors were transplanted at either 200,000, 1 million, or 2 million cells per animal. Interestingly, the smaller transplants were more likely to extend neuronal fibers and less likely to provoke immune rejection than the largest transplants in this xenograft model. Cellular proliferation continued immediately post-transplantation, but by 20 weeks there were virtually no dividing cells within any of the grafts. In contrast, fiber outgrowth increased gradually over time and often occupied the entire striatum at 20 weeks postgrafting. Transient expression of tyrosine hydroxylase-positive cells within the grafts was found in some animals, but this was not sustained at 20 weeks and had no functional effects. For Parkinson's disease, the principal aim now is to induce the dopaminergic phenotype in these cells prior to transplantation. However, given the relative safety profile for these human cells and their capacity to extend fibers into the adult rodent brain, they may provide the ideal basis for the repair of other lesions of the CNS where extensive axonal outgrowth is required. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877932     DOI: 10.1006/exnr.2000.7427

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  55 in total

1.  Transplantation dose alters the dynamics of human neural stem cell engraftment, proliferation and migration after spinal cord injury.

Authors:  Katja M Piltti; Sabrina N Avakian; Gabriella M Funes; Antoinette Hu; Nobuko Uchida; Aileen J Anderson; Brian J Cummings
Journal:  Stem Cell Res       Date:  2015-07-26       Impact factor: 2.020

Review 2.  Stem cell myths.

Authors:  Tim Magnus; Ying Liu; Graham C Parker; Mahendra S Rao
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

3.  Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease.

Authors:  Brian W Leonard; Diego Mastroeni; Andrew Grover; Qiang Liu; Kechun Yang; Ming Gao; Jie Wu; David Pootrakul; Simone A van den Berge; Elly M Hol; Joseph Rogers
Journal:  J Comp Neurol       Date:  2009-07-20       Impact factor: 3.215

4.  Effects of Sertoli cell-conditioned medium on ventral midbrain neural stem cells: a preliminary report.

Authors:  Rania Shamekh; Samuel Saporta; Don F Cameron; Alison E Willing; Cindy D Sanberg; Karl Johe; P R Sanberg
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

5.  Comparison of different culture modes for long-term expansion of neural stem cells.

Authors:  Ke Zheng; Tian-Qing Liu; Ming-Shu Dai; Dan Ge; Xiang-Qin Li; Xue-Hu Ma; Zhan-Feng Cui
Journal:  Cytotechnology       Date:  2006-12-19       Impact factor: 2.058

6.  Prospective identification, isolation, and profiling of a telomerase-expressing subpopulation of human neural stem cells, using sox2 enhancer-directed fluorescence-activated cell sorting.

Authors:  Su Wang; Devin Chandler-Militello; Gang Lu; Neeta S Roy; Alex Zielke; Romane Auvergne; Nancy Stanwood; Daniel Geschwind; Giovanni Coppola; Silvia K Nicolis; Fraser J Sim; Steven A Goldman
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

7.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

8.  Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis.

Authors:  Nicole L Nichols; Genevieve Gowing; Irawan Satriotomo; Lisa J Nashold; Erica A Dale; Masatoshi Suzuki; Pablo Avalos; Patrick L Mulcrone; Jacalyn McHugh; Clive N Svendsen; Gordon S Mitchell
Journal:  Am J Respir Crit Care Med       Date:  2012-12-06       Impact factor: 21.405

9.  Molecular cloning and characterization of the zebrafish (Danio rerio) telomerase catalytic subunit (telomerase reverse transcriptase, TERT).

Authors:  Benson Wui-Man Lau; Anderson On-Lam Wong; George Sai-Wah Tsao; Kwok-Fai So; Henry Ka-Fun Yip
Journal:  J Mol Neurosci       Date:  2007-09-19       Impact factor: 3.444

10.  Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats.

Authors:  Dali Yang; Zhi-Jian Zhang; Michael Oldenburg; Melvin Ayala; Su-Chun Zhang
Journal:  Stem Cells       Date:  2007-10-18       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.